<b>Background and Objectives:</b> Aberrant activation or overexpression of cell division cycle 42 (Cdc42) has been demonstrated in various tumors; however, its prognostic relevance in colorectal cancer (CRC) remains insufficiently defined. This evidence concerns the gene CDC42 and colorectal carcinoma.